Digest Network Come funziona
Network
/
Società
Nu
Non verificato

Nuvig Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

4 comunicati stampa

Guarda tutti i comunicati
18/11/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato del lavoro
Nuvig Therapeutics Appoints Celia J.F. Lin, M.D., as Chief Medical Officer
Fonte
Nuvig Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/09/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato del lavoro
Nuvig Therapeutics Appoints David J. Woodhouse, Ph.D., as Chief Executive Officer and James Mackay, Ph.D., as Independent Board Chair
Fonte
Nuvig Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/05/2025
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Sanità
Nuvig Therapeutics Announces First Patient Dosed in Phase 2 CIDP Trial of NVG-2089 and Presentation of Phase 1 Data
Fonte
Nuvig Therapeutics, Inc.
Emittente
Business Wire
1.00
0
05/12/2024
Mercato del lavoro
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator
Fonte
Nuvig Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0